Foresight Diagnostics lab (courtesy Foresight)

Fore­sight Di­ag­nos­tic­s' ap­proach for the ear­li­er de­tec­tion of can­cer re­cur­rence pulls in near­ly $59M

In a crowd­ed field of can­cer di­ag­nos­tics com­pa­nies look­ing to de­tect re­laps­es ear­li­er, Fore­sight Di­ag­nos­tics thinks it has a more sen­si­tive ap­proach. On Thurs­day, it …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.